Outcomes with sorafenib (SOR) followed by regorafenib (REG) or placebo (PBO) for hepatocellular carcinoma (HCC): results of the international, randomized phase 3 RESORCE trial

被引：0

作者：

Woerns, M. -A. ^{[1
]}

Finn, R. S. ^{[2
]}

Merle, P. ^{[3
]}

Granito, A. ^{[4
]}

Huang, Y. -H. ^{[5
]}

Bodoky, G. ^{[6
]}

Pracht, M. ^{[7
]}

Yokosuka, O. ^{[8
]}

Rosmorduc, O. ^{[9
]}

Gerolami, R. ^{[10
]}

Caparello, C. ^{[11
]}

Cabrera, R. ^{[12
]}

Chang, C. ^{[13
]}

Sun, W. ^{[14
]}

LeBerre, M. -A. ^{[15
]}

Baumhauer, A. ^{[16
]}

Meinhardt, G. ^{[17
]}

Galle, P. ^{[18
]}

Bruix, J. ^{[19
]}

机构：

[1] Univ Med Mainz, Med Klin 1, Mainz, Germany

[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[3] Grp Hosp Lyon Nord, Lyon, France

[4] St Orsola Marcello Malpighi Hosp, Bologna, Italy

[5] Taipei Vet Gen Hosp, Taipei, Taiwan

[6] St Laszlo Teaching Hosp, Budapest, Hungary

[7] Serv Oncol Med, Rennes, France

[8] Chiba Univ, Chiba, Japan

[9] Hop La Pitie Salpetriere, Paris, France

[10] CHU Timone, Marseille, France

[11] Azienda Osped Univ Pisana, Pisa, Italy

[12] Univ Florida, Hlth Canc Ctr, Gainesville, FL USA

[13] Mt Sinai Med Ctr, New York, NY 10029 USA

[14] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA

[15] Bayer Healthcare SAS, Loos, France

[16] Bayer Pharamceut, Leverkusen, Germany

[17] Bayer Healthcare Pharmaceut, Whippany, NJ USA

[18] Univ Med Mainz, Mainz, Germany

[19] Univ Barcelona, Hosp Clin, Liver Unit, Barcelona, Spain

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P574

引用

页码：161 / 161

页数：1